Literature DB >> 14530213

Effects of endomorphin on substantia gelatinosa neurons in rat spinal cord slices.

Su-Ying Wu1, Yoshitaka Ohtubo, G Cristina Brailoiu, Nae J Dun.   

Abstract

1. Whole-cell patch recordings were made from substantia gelatinosa (SG) neurons in transverse lumbar spinal cord slices of 15- to 30-day-old rats. 2. Endomorphin 1 (EM-1) or EM-2 (<or=10 microM) hyperpolarized or induced an outward current in 26 of the 66 SG neurons. The I-V relationship showed that the peptide activates an inwardly rectifying K+ current. 3. EM-1 or EM-2 (0.3-10 microM) suppressed short-latency excitatory postsynaptic currents (EPSCs) and long-latency inhibitory postsynaptic currents (IPSCs) in nearly all SG neurons tested or short-latency IPSCs in six of the 10 SG neurons. [Met5] enkephalin or [d-Ala2, N-Me-Phe4, Gly5-ol]-enkephalin (DAMGO) (1-10 microM) depressed EPSCs and IPSCs. EM-1 or EM-2 depressed synaptic responses without causing a significant change in holding currents or inward currents induced by glutamate. 4. Glutamate also evoked a short-latency outward current in five SG neurons or a biphasic current in two neurons; the outward current was blocked by tetrodotoxin (TTX, 0.3 microM) or bicuculline (10 microM). 5. EM-1 or DAMGO (1 or 5 microM) attenuated the glutamate-evoked outward or biphasic currents in four of the seven SG neurons. EM-1 (1 microm) reduced the frequency, but not the amplitude of miniature EPSCs or miniature IPSCs. 6.. Naloxone (1 microM) or the selective micro-opioid receptor antagonist beta-funaltrexamine (beta-FNA, 25 microM) antagonized the action of EM; EM-induced hyperpolarizations persisted in the presence of the kappa-opioid receptor antagonist (nor-binaltorphimine dihydrochloride, 1 microM) and/or sigma-opioid receptor antagonist (naltrindole hydrochloride, 1 microM). 7. It may be concluded that EM acting on micro-opioid receptors hyperpolarizes a population of SG neurons by activating an inwardly rectifying K+ current, and attenuates excitatory and inhibitory synaptic currents evoked in a population of SG neurons, probably by a presynaptic site of action.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14530213      PMCID: PMC1574121          DOI: 10.1038/sj.bjp.0705534

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  44 in total

1.  Immunohistochemical localization of mu-opioid receptors in the central nervous system of the rat.

Authors:  Y Q Ding; T Kaneko; S Nomura; N Mizuno
Journal:  J Comp Neurol       Date:  1996-04-08       Impact factor: 3.215

2.  Spinal analgesic actions of the new endogenous opioid peptides endomorphin-1 and -2.

Authors:  L S Stone; C A Fairbanks; T M Laughlin; H O Nguyen; T M Bushy; M W Wessendorf; G L Wilcox
Journal:  Neuroreport       Date:  1997-09-29       Impact factor: 1.837

3.  Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene.

Authors:  H W Matthes; R Maldonado; F Simonin; O Valverde; S Slowe; I Kitchen; K Befort; A Dierich; M Le Meur; P Dollé; E Tzavara; J Hanoune; B P Roques; B L Kieffer
Journal:  Nature       Date:  1996-10-31       Impact factor: 49.962

4.  The mu-opioid receptor (MOR1) is mainly restricted to neurons that do not contain GABA or glycine in the superficial dorsal horn of the rat spinal cord.

Authors:  T Kemp; R C Spike; C Watt; A J Todd
Journal:  Neuroscience       Date:  1996-12       Impact factor: 3.590

5.  A potent and selective endogenous agonist for the mu-opiate receptor.

Authors:  J E Zadina; L Hackler; L J Ge; A J Kastin
Journal:  Nature       Date:  1997-04-03       Impact factor: 49.962

6.  Release of endomorphin-2 like substances from the rat spinal cord.

Authors:  C A Williams; S Y Wu; S L Dun; E H Kwok; N J Dun
Journal:  Neurosci Lett       Date:  1999-09-24       Impact factor: 3.046

7.  Inhibitory actions of delta 1-, delta 2-, and mu-opioid receptor agonists on excitatory transmission in lamina II neurons of adult rat spinal cord.

Authors:  S R Glaum; R J Miller; D L Hammond
Journal:  J Neurosci       Date:  1994-08       Impact factor: 6.167

8.  Blind patch-clamp recordings from substantia gelatinosa neurons in adult rat spinal cord slices: pharmacological properties of synaptic currents.

Authors:  M Yoshimura; S Nishi
Journal:  Neuroscience       Date:  1993-03       Impact factor: 3.590

9.  Primary afferent-evoked glycine- and GABA-mediated IPSPs in substantia gelatinosa neurones in the rat spinal cord in vitro.

Authors:  M Yoshimura; S Nishi
Journal:  J Physiol       Date:  1995-01-01       Impact factor: 5.182

10.  ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization.

Authors:  C Mollereau; M Parmentier; P Mailleux; J L Butour; C Moisand; P Chalon; D Caput; G Vassart; J C Meunier
Journal:  FEBS Lett       Date:  1994-03-14       Impact factor: 4.124

View more
  8 in total

Review 1.  Opioid system and Alzheimer's disease.

Authors:  Zhiyou Cai; Anna Ratka
Journal:  Neuromolecular Med       Date:  2012-04-22       Impact factor: 3.843

2.  Synaptic input of rat spinal lamina I projection and unidentified neurones in vitro.

Authors:  Anne Dahlhaus; Ruth Ruscheweyh; Jürgen Sandkühler
Journal:  J Physiol       Date:  2005-05-05       Impact factor: 5.182

3.  Excitatory effects of human immunodeficiency virus 1 Tat on cultured rat cerebral cortical neurons.

Authors:  G C Brailoiu; E Brailoiu; J K Chang; N J Dun
Journal:  Neuroscience       Date:  2007-12-05       Impact factor: 3.590

4.  Endomorphin-2 Inhibition of Substance P Signaling within Lamina I of the Spinal Cord Is Impaired in Diabetic Neuropathic Pain Rats.

Authors:  Fa-Ping Wan; Yang Bai; Zhen-Zhen Kou; Ting Zhang; Hui Li; Ya-Yun Wang; Yun-Qing Li
Journal:  Front Mol Neurosci       Date:  2017-01-10       Impact factor: 5.639

5.  Chemokine CCL2 prevents opioid-induced inhibition of nociceptive synaptic transmission in spinal cord dorsal horn.

Authors:  Mario Heles; Petra Mrozkova; Dominika Sulcova; Pavel Adamek; Diana Spicarova; Jiri Palecek
Journal:  J Neuroinflammation       Date:  2021-12-02       Impact factor: 8.322

6.  Kappa opioids inhibit the GABA/glycine terminals of rostral ventromedial medulla projections in the superficial dorsal horn of the spinal cord.

Authors:  Yo Otsu; Karin R Aubrey
Journal:  J Physiol       Date:  2022-09-02       Impact factor: 6.228

7.  The effect of µ-opioid receptor activation on GABAergic neurons in the spinal dorsal horn.

Authors:  Yoo Rim Kim; Hyun Geun Shim; Chang-Eop Kim; Sang Jeong Kim
Journal:  Korean J Physiol Pharmacol       Date:  2018-06-25       Impact factor: 2.016

Review 8.  Cellular Mechanisms for Antinociception Produced by Oxytocin and Orexins in the Rat Spinal Lamina II-Comparison with Those of Other Endogenous Pain Modulators.

Authors:  Eiichi Kumamoto
Journal:  Pharmaceuticals (Basel)       Date:  2019-09-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.